Nikolaos Grivas1, Esther Wit2, Corinne Tillier2, Erik van Muilekom2, Floris Pos3, Alexander Winter4, Henk van der Poel2. 1. Department of Urology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066, CX, Amsterdam, The Netherlands. n.grivas@nki.nl. 2. Department of Urology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066, CX, Amsterdam, The Netherlands. 3. Department of Radiation Oncology, The Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands. 4. University Hospital for Urology, Klinikum Oldenburg, School of Medicine and Health Sciences, Carl von Ossietzky University, Oldenburg, Germany.
Abstract
PURPOSE: The updated Winter nomogram is the only nomogram predicting lymph node invasion (LNI) in prostate cancer (PCa) patients based on sentinel node (SN) dissection (sLND). The aim of the study was to externally validate the Winter nomogram and examine its performance in patients undergoing extended pelvic lymph node dissection (ePLND), ePLND combined with SN biopsy (SNB) and sLND only. The results were compared with the Memorial Sloan Kettering Cancer Center (MSKCC) and updated Briganti nomograms. METHODS: This retrospective study included 1183 patients with localized PCa undergoing robot-assisted laparoscopic radical prostatectomy (RARP) combined with pelvic lymphadenectomy and 224 patients treated with sLND and external beam radiotherapy (EBRT), aiming to offer pelvic radiotherapy only in case of histologically positive SNs. In the RARP population, ePLND was applied in 956 (80.8%) patients,while 227 (19.2%) patients were offered ePLND combined with additional SNB. RESULTS: The median numbers of removed nodes were 10 (interquartile range, IQR = 6-14), 15 (IQR = 10-20) and 7 (IQR = 4-10) in the ePLND, ePLND + SNB, and sLND groups, respectively. Corresponding LNI rates were 16.6%, 25.5% and 42%. Based on the AUC, the performance of the Briganti nomogram (0.756) in the ePLND group was superior to both the MSKCC (0.744) and Winter nomogram (0.746). The Winter nomogram, however, was the best predictor of LNI in both the ePLND + SNB (0.735) and sLND (0.709) populations. In the calibration analysis, all nomograms showed better accuracy in the low/intermediate risk patients, while in the high-risk population, an overestimation of the risk for LNI was observed. CONCLUSION: The SN-based updated nomogram showed better prediction in the SN population. The results were also comparable, relative to predictive tools developed with (e)PLND, suggesting a difference in sampling accuracy between SNB and non-SNB. Patients who benefit most from the nomogram would be those with a low/intermediate risk of LN metastasis.
PURPOSE: The updated Winter nomogram is the only nomogram predicting lymph node invasion (LNI) in prostate cancer (PCa) patients based on sentinel node (SN) dissection (sLND). The aim of the study was to externally validate the Winter nomogram and examine its performance in patients undergoing extended pelvic lymph node dissection (ePLND), ePLND combined with SN biopsy (SNB) and sLND only. The results were compared with the Memorial Sloan Kettering Cancer Center (MSKCC) and updated Briganti nomograms. METHODS: This retrospective study included 1183 patients with localized PCa undergoing robot-assisted laparoscopic radical prostatectomy (RARP) combined with pelvic lymphadenectomy and 224 patients treated with sLND and external beam radiotherapy (EBRT), aiming to offer pelvic radiotherapy only in case of histologically positive SNs. In the RARP population, ePLND was applied in 956 (80.8%) patients,while 227 (19.2%) patients were offered ePLND combined with additional SNB. RESULTS: The median numbers of removed nodes were 10 (interquartile range, IQR = 6-14), 15 (IQR = 10-20) and 7 (IQR = 4-10) in the ePLND, ePLND + SNB, and sLND groups, respectively. Corresponding LNI rates were 16.6%, 25.5% and 42%. Based on the AUC, the performance of the Briganti nomogram (0.756) in the ePLND group was superior to both the MSKCC (0.744) and Winter nomogram (0.746). The Winter nomogram, however, was the best predictor of LNI in both the ePLND + SNB (0.735) and sLND (0.709) populations. In the calibration analysis, all nomograms showed better accuracy in the low/intermediate risk patients, while in the high-risk population, an overestimation of the risk for LNI was observed. CONCLUSION: The SN-based updated nomogram showed better prediction in the SN population. The results were also comparable, relative to predictive tools developed with (e)PLND, suggesting a difference in sampling accuracy between SNB and non-SNB. Patients who benefit most from the nomogram would be those with a low/intermediate risk of LN metastasis.
Authors: J Schmitges; P I Karakiewicz; M Sun; F Abdollah; L Budäus; H Isbarn; M Bianchi; Q-D Trinh; T Schlomm; F K Chun; M Graefen; T Steuber Journal: Eur J Surg Oncol Date: 2012-04-22 Impact factor: 4.424
Authors: Alberto Briganti; Felix K-H Chun; Andrea Salonia; Giuseppe Zanni; Vincenzo Scattoni; Luc Valiquette; Patrizio Rigatti; Francesco Montorsi; Pierre I Karakiewicz Journal: Eur Urol Date: 2006-02-17 Impact factor: 20.096
Authors: Esther M K Wit; Cenk Acar; Nikolaos Grivas; Cathy Yuan; Simon Horenblas; Fredrik Liedberg; Renato A Valdes Olmos; Fijs W B van Leeuwen; Nynke S van den Berg; Alexander Winter; Friedhelm Wawroschek; Stephan Hruby; Günter Janetschek; Sergi Vidal-Sicart; Steven MacLennan; Thomas B Lam; Henk G van der Poel Journal: Eur Urol Date: 2016-09-14 Impact factor: 20.096
Authors: Nikolaos Grivas; Esther Wit; Floris Pos; Jeroen de Jong; Erik Vegt; Axel Bex; Kees Hendricksen; Simon Horenblas; Gijs KleinJan; Bas van Rhijn; Henk van der Poel Journal: Int J Radiat Oncol Biol Phys Date: 2016-10-19 Impact factor: 7.038
Authors: Karim Touijer; Farhang Rabbani; Javier Romero Otero; Fernando P Secin; James A Eastham; Peter T Scardino; Bertrand Guillonneau Journal: J Urol Date: 2007-05-11 Impact factor: 7.450
Authors: Alberto Briganti; Umberto Capitanio; Felix K-H Chun; Andrea Gallina; Nazareno Suardi; Andrea Salonia; Luigi F Da Pozzo; Renzo Colombo; Valerio Di Girolamo; Roberto Bertini; Giorgio Guazzoni; Pierre I Karakiewicz; Francesco Montorsi; Patrizio Rigatti Journal: Eur Urol Date: 2008-05-21 Impact factor: 20.096
Authors: Alexander Winter; Thomas Kneib; Clara Wasylow; Lena Reinhardt; Rolf-Peter Henke; Svenja Engels; Holger Gerullis; Friedhelm Wawroschek Journal: J Cancer Date: 2017-08-22 Impact factor: 4.207
Authors: Sherif Mehralivand; Henk van der Poel; Alexander Winter; Peter L Choyke; Peter A Pinto; Baris Turkbey Journal: Transl Androl Urol Date: 2018-10